Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
The Journal of Experimental Medicine|March 20, 2013
Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapiesJulien Ablain, Magdalena Leiva, Laurent Peres, et al.Nanoscale|May 6, 2021
An air-stable, reusable Ni@Ni(OH)2 nanocatalyst for CO2/bicarbonate hydrogenation to formateXin-Pu Fu, Laurent Peres, Jérôme Esvan, et al.Cancer Cell|February 16, 2005
A sumoylation site in PML/RARA is essential for leukemic transformationJun Zhu, Jun Zhou, Laurent Peres, et al.Nanoscale Advances|September 22, 2022
Correlation between surface chemistry and magnetism in iron nanoparticlesLorraine Haim, François Robert, Laurent Peres, et al.Plos One|August 15, 2014
The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformationXi Liu, Hao Yuan, Laurent Peres, et al.Angewandte Chemie (International Ed. in English)|June 13, 2018
hcp-Co Nanowires Grown on Metallic Foams as Catalysts for Fischer-Tropsch SynthesisJustine Harmel, Laurent Peres, Marta Estrader, et al.Blood|September 27, 2014
Clearance of PML/RARA-bound promoters suffice to initiate APL differentiationAdeline Vitaliano-Prunier, Juliane Halftermeyer, Julien Ablain, et al.Nature Communications|June 20, 2014
Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replicationUmut Sahin, Omar Ferhi, Xavier Carnec, et al.Nature Cell Biology|April 15, 2008
Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathwayValérie Lallemand-Breitenbach, Marion Jeanne, Shirine Benhenda, et al.Cancer Cell|July 9, 2010
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3Marion Jeanne, Valérie Lallemand-Breitenbach, Omar Ferhi, et al.Pageof 2